AI in Drug Discovery | BenevolentAI

AI in Drug Discovery | BenevolentAI

This blog seeks to demystify the application of artificial intelligence (AI) and machine learning (ML) in drug discovery by exploring some of the challenges, opportunities and progress that has been achieved in the field so far.

The challenges of applying AI and machine learning (ML) in drug discovery

The opportunities: how AI is improving drug discovery

From promise to reality: successes in AI drug discovery

AI in drug discovery: what’s next?

Rachel Hodos, Lead AI Scientist for Target Identification, BenevolentAI
Nathan Brown, Director of Cheminformatics & Computational Chemistry, BenevolentAI
Aylin Cakiroglu, Senior AI Scientist for Precision Medicine, BenevolentAI

--

--

Uniting human and machine intelligence to discover new ways to treat disease | www.benevolent.com #Becauseitmatters #AI #DrugDiscovery #Innovation

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
BenevolentAI

Uniting human and machine intelligence to discover new ways to treat disease | www.benevolent.com #Becauseitmatters #AI #DrugDiscovery #Innovation